China SXT Pharmaceuticals, Inc. (SXTC): Price and Financial Metrics
GET POWR RATINGS... FREE!
SXTC POWR Grades
- SXTC scores best on the Sentiment dimension, with a Sentiment rank ahead of 79.4% of US stocks.
- The strongest trend for SXTC is in Sentiment, which has been heading down over the past 41 days.
- SXTC ranks lowest in Quality; there it ranks in the 1st percentile.
SXTC Stock Summary
- With a market capitalization of $1,249,307, CHINA SXT PHARMACEUTICALS INC has a greater market value than just 0.07% of US stocks.
- The volatility of CHINA SXT PHARMACEUTICALS INC's share price is greater than that of 97.23% US stocks with at least 200 days of trading history.
- CHINA SXT PHARMACEUTICALS INC's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -432.93%, greater than the shareholder yield of only 1.29% of stocks in our set.
- If you're looking for stocks that are quantitatively similar to CHINA SXT PHARMACEUTICALS INC, a group of peers worth examining would be WORX, TIRX, CDMO, SGBX, and CLOV.
- SXTC's SEC filings can be seen here. And to visit CHINA SXT PHARMACEUTICALS INC's official web site, go to www.sxtchina.com.
SXTC Valuation Summary
- In comparison to the median Healthcare stock, SXTC's EV/EBIT ratio is 73.26% lower, now standing at 2.3.
- Over the past 47 months, SXTC's EV/EBIT ratio has gone down 76.9.
Below are key valuation metrics over time for SXTC.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| SXTC | 2022-11-25 | 3.5 | 0.1 | -0.2 | 2.3 |
| SXTC | 2022-11-23 | 3.5 | 0.1 | -0.2 | 2.3 |
| SXTC | 2022-11-22 | 3.5 | 0.1 | -0.2 | 2.3 |
| SXTC | 2022-11-21 | 3.5 | 0.1 | -0.2 | 2.3 |
| SXTC | 2022-11-18 | 3.8 | 0.1 | -0.2 | 2.3 |
| SXTC | 2022-11-17 | 4.1 | 0.1 | -0.2 | 2.3 |
SXTC Stock Price Chart Interactive Chart >
SXTC Price/Volume Stats
| Current price | $0.64 | 52-week high | $15.80 |
| Prev. close | $0.61 | 52-week low | $0.52 |
| Day low | $0.60 | Volume | 207,944 |
| Day high | $0.69 | Avg. volume | 329,858 |
| 50-day MA | $0.70 | Dividend yield | N/A |
| 200-day MA | $2.19 | Market Cap | 1.29M |
China SXT Pharmaceuticals, Inc. (SXTC) Company Bio
China Sxt Pharmaceuticals, Inc. engages in the development, manufacture, marketing, sales, research and development of Chinese traditional medicine. It sells Advanced TCMP, Fine TCMP and Regular TCMP products. The company sell its products under "Suxuantang" brand name. The company was founded by Zhou Feng in 2005 and is headquartered in Taizhou, China.
Latest SXTC News From Around the Web
Below are the latest news stories about CHINA SXT PHARMACEUTICALS INC that investors may wish to consider to help them evaluate SXTC as an investment opportunity.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on FridayGet ready for one more day of trading this week as we break down the biggest pre-market stock movers for Friday morning! |
China SXT Pharmaceuticals, Inc. Announces 1 for 20 Reverse Share SplitTAIZHOU, China, May 18, 2022 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces ("TCMPs"), including Advanced TCMPs (Directly-Oral TCMP and After-Soaking-Oral TCMP), fine TCMPs, regular TCMPs, and TCM Homologous Supplements ("TCMHS") announced today that an 1 for 20 reverse split of its ordinary shares |
China SXT Pharmaceuticals, Inc. Enters into Securities Purchase Agreement to Issue a 6% Convertible Promissory Note in the Original Principal Amount of $2.8 MillionTAIZHOU, China, March 14, 2022 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. ("SXTC" or the "Company"), (NASDAQ: SXTC), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces ("TCMPs"), including Advanced TCMPs (Directly-Oral TCMP and After-Soaking-Oral TCMP), fine TCMPs, regular TCMPs, and TCM Homologous Supplements ("TCMHS"), today announced that it entered into a securities purchase agreement t |
Aegis Capital Corp. Acted as Sole Bookrunner on a $4.1 Million Underwritten Public Offering of Ordinary Shares, Inclusive of the Over-Allotment, for China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC).NEW YORK, NY / ACCESSWIRE /January 20, 2022 / Aegis Capital Corp. acted as Sole Bookrunner on a $4. |
China SXT Pharmaceuticals, Inc. Announces Successful Closing of $4.1 Million Follow-on Underwritten Offering of Ordinary Shares and Pre-Funded Warrants With Simultaneous Exercise of the Over-AllotmentTAIZHOU, China, Jan. 20, 2022 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. ("SXTC" or the "Company"), (NASDAQ: SXTC), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces ("TCMPs"), including Advanced TCMPs (Directly-Oral TCMP and After-Soaking-Oral TCMP), fine TCMPs, regular TCMPs, and TCM Homologous Supplements ("TCMHS"), today announced the closing of an underwritten public offering (the “Of |
SXTC Price Returns
| 1-mo | 1.44% |
| 3-mo | -54.45% |
| 6-mo | -66.84% |
| 1-year | -95.72% |
| 3-year | -99.10% |
| 5-year | N/A |
| YTD | -95.08% |
| 2021 | -50.54% |
| 2020 | -59.91% |
| 2019 | N/A |
| 2018 | N/A |
| 2017 | N/A |
Continue Researching SXTC
Here are a few links from around the web to help you further your research on China SXT Pharmaceuticals Inc's stock as an investment opportunity:China SXT Pharmaceuticals Inc (SXTC) Stock Price | Nasdaq
China SXT Pharmaceuticals Inc (SXTC) Stock Quote, History and News - Yahoo Finance
China SXT Pharmaceuticals Inc (SXTC) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...